glipizide has been researched along with Compensatory Hyperinsulinemia in 2 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hypoglycemia was severe and required multiple dextrose boluses in addition to continuous dextrose infusion for 36 hours." | 5.35 | Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide. ( Abramson, E; Pelavin, PI; Pon, S; Vogiatzi, MG, 2009) |
| "The hypoglycemia was severe and required multiple dextrose boluses in addition to continuous dextrose infusion for 36 hours." | 1.35 | Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide. ( Abramson, E; Pelavin, PI; Pon, S; Vogiatzi, MG, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pelavin, PI | 1 |
| Abramson, E | 1 |
| Pon, S | 1 |
| Vogiatzi, MG | 1 |
| Sheu, WH | 1 |
| Jeng, CY | 1 |
| Fuh, MM | 1 |
| Chen, YD | 1 |
| Reaven, GM | 1 |
2 other studies available for glipizide and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide.
Topics: Child; Drug Overdose; Female; Gastrointestinal Agents; Glipizide; Glucose; Humans; Hyperinsulinism; | 2009 |
Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationshi | 1995 |